|

Rapamycin (sirolimus) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Rapamune

Pipeline

Phase 1/2: 1

Top Sponsors

  • Umoja Biopharma1

Indications

  • Primary Mediastinal B-cell Lymphoma1
  • Richter Transformation Lymphoma1
  • Lymphoma, B-Cell1
  • Grade 3b Follicular Lymphoma1
  • High-grade B-cell Lymphoma1

Nashville, Tennessee1 trial

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.